Clinical study on prevention and treatment of peritoneal metastatic colorectal cancer

doi:10.16139/j.1007-9610.2021.01.002

Abstract

CLC Number:

Guan Tianpei, Lei ziying, Cui Shuzhong. Clinical study on prevention and treatment of peritoneal metastatic colorectal cancer[J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 7-10.

Figures/Tables 1

References 28

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3]	Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database[J]. Lancet Oncol, 2016, 17(12):1709-1719. doi: S1470-2045(16)30500-9 pmid: 27743922
[4]	Hompes D, Tiek J, Wolthuis A, et al. HIPEC in T_4acolon cancer: a defendable treatment to improve oncologic outcome?[J]. Ann Oncol, 2012, 23(12):3123-3129. doi: S0923-7534(19)37483-6 pmid: 32018819
[5]	Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer[J]. Br J Surg, 2012, 99(5):699-705. doi: 10.1002/bjs.8679 pmid: 22287157
[6]	Razenberg LG, van Gestel YR, Creemers GJ, et al. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands[J]. Eur J Surg Oncol, 2015, 41(4):466-471. doi: 10.1016/j.ejso.2015.01.018 pmid: 25680955
[7]	Lambert LA. Looking up: recent advances in understan-ding and treating peritoneal carcinomatosis[J]. CA Cancer J Clin, 2015, 65(4):284-298.
[8]	Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy[J]. J Clin Oncol, 2012, 30(20):2449-2456.
[9]	van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer[J]. N Engl J Med, 2018, 378(3):230-240.
[10]	Lei Z, Wang Y, Wang J, et al. Evaluation of cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stageⅢ epithelial ovarian cancer[J]. JAMA Netw Open, 2020, 3(8):e2013940.
[11]	Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis[J]. J Clin Oncol, 2019, 37(23):2028-2040.
[12]	Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. NCCN guidelines insights: ovarian cancer, version 1.2019[J]. J Natl Compr Canc Netw, 2019, 17(8):896-909.
[13]	Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer[J]. J Clin Oncol, 2003, 21(20):3737-3743. pmid: 14551293
[14]	Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin[J]. J Clin Oncol, 2009, 27(5):681-685.
[15]	Franko J, Ibrahim Z, Gusani NJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis[J]. Cancer, 2010, 116(16):3756-3762. doi: 10.1002/cncr.25116 pmid: 20564081
[16]	Cashin PH, Graf W, Nygren P, et al. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study[J]. Eur J Surg Oncol, 2012, 38(6):509-515. doi: 10.1016/j.ejso.2012.03.001 pmid: 22475555
[17]	Quenet F, Elias D, Roca L, et al. A UNICANCER phase Ⅲ trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. PRODIGE 7[J]. Eur J Surg Oncol, 2019, 45(2):e17.
[18]	Goere D, Glehen O, Quenet F, et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing co-lorectal peritoneal metastases(PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study[J]. Lancet Oncol, 2020, 21(9):1147-1154.
[19]	Nagourney RA, Evans S, Tran PH, et al. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin[J]. Eur J Surg Oncol, 2020, S0748-7983(20):30789.
[20]	Bando H, Kagawa Y, Kato T, et al. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer[J]. Br J Cancer, 2019, 120(10):982-986.
[21]	Schweiger T, Liebmann-Reindl S, Glueck O, et al. Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgery[J]. J Thorac Dis, 2018, 10(11):6147-6157. doi: 10.21037/jtd.2018.10.72 pmid: 30622786
[22]	Sammartino P, Sibio S, Biacchi D, et al. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases[J]. Int J Colorectal Dis, 2014, 29(9):1081-1089. doi: 10.1007/s00384-014-1929-4 pmid: 24980687
[23]	Klaver C, Wisselink DD, Punt C, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial[J]. Lancet Gastroenterol Hepatol, 2019, 4(10):761-770.
[24]	雷子颖, 关天培, 罗嘉莉, 等. 局部进展期结直肠癌原发肿瘤切除术后5-8周行腹腔热灌注化疗的合理性[J]. 中华胃肠外科杂志, 2019, 22(12):1115-1116.
[25]	Becerra AZ, Aquina CT, Mohile SG, et al. Variation in delayed time to adjuvant chemotherapy and disease-specific survival in stage Ⅲ colon cancer patients[J]. Ann Surg Oncol, 2017, 24(6):1610-1617. doi: 10.1245/s10434-016-5622-4 pmid: 27738848
[26]	Elias D, Goere D, Dumont F, et al. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases[J]. Eur J Cancer, 2014, 50(2):332-340. doi: 10.1016/j.ejca.2013.09.024 pmid: 24157254
[27]	蔡国响, 崔书中, 陈凛, 等. 腹腔热灌注化疗技术临床应用专家共识(2016版)[J]. 中华胃肠外科杂志, 2016, 19(2):121-125.
[28]	中国抗癌协会腹膜肿瘤专业委员会, 广东省抗癌协会肿瘤热疗专业委员会. 中国腹腔热灌注化疗技术临床应用专家共识(2019版)[J]. 中华医学杂志, 2020, 100(2):89-90.

Clinical study on prevention and treatment of peritoneal metastatic colorectal cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 28

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHENG Minhua, MA Junjun. Laparoscopic colorectal surgery 30 years in China: what we learned [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 181-185.
[2]	SUN Yueming, ZHANG Dongsheng. Controversy over the medial border of lymph node dissection during CME/D3 surgery of right colon cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 202-207.
[3]	YIN Jianguang, ZONG Yaping, SHEN Xiaohui, ZHAO Jingkun, LU Aiguo. Analysis of treatment and prognosis of synchronous multiple primary colorectal cancer: a report of 39 cases [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 540-544.
[4]	XU Zifeng, ZONG Yaping, LU Aiguo. Neoadjuvant therapy in patients with locally advanced colon cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 266-270.
[5]	BAO Quan, XING Baocai. Surgical treatment strategy for complex bilateral multiple liver metastases of colorectal carcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130.
[6]	SHAO Jiazhe, ZHOU Guoqiang, GUO Jian, LIU Kun, ZHAO Ren. A retrospective study on single-incision laparoscoic surgery for right colonic cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 70-75.
[7]	LIU Shiguang, ZHAO Jingkun, LU Aiguo, MAO Zhihai. Expression of chemokine CXCL5 and programme death ligand 1 in colorectal cancer tissues are associated with prognosis of patients [J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 543-549.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 277-280.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 290-296.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 312-317.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 318-324.
[12]	WU Chunxiao, GONG Yangming, GU Kai, PANG Yi, BAO Pingping, WANG Chunfang, SHI Liang, XIANG Yongmei, DOU Jianming, FU Chen, SHI Yan. Colorectal cancer incidence and mortality in Shanghai 2016 and trend analysis 2002—2016 [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 325-335.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 281-284.
[14]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 297-299.
[15]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 300-304.